Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine vs. Pioglitazone in Type 2 Diabetes
NCT02303405Phase 2Terminated
- Sponsor
- Charles Drew University of Medicine & Science
- Start
- Nov 2014
- Primary completion
- Nov 2017
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine in type 2 diabetes mellitus (T2DM), sponsored by Charles Drew University of Medicine & Science. Started Nov 2014; status: terminated.
02
Drugs
hydroxychloroquine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02303405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02303405.